
Please try another search
Veridian (VRDG) reported its Q2 2025 earnings, showcasing a robust financial performance with an 8% year-on-year increase in total segment revenue to $575 million. According to InvestingPro data, the...
Viridien SA (NASDAQ:VIRI) presented its Q2 and H1 2025 financial results on July 31, 2025, highlighting solid performance across its segments despite volatile oil prices. The company reported 6%...
Viridien SA reported a strong financial performance for the first quarter of 2025, with a 10% increase in revenue year-over-year, reaching $301 million. Despite these solid earnings, the company's...
Introduction & Market ContextViridien SA (VIRI) released its fourth quarter and full-year 2024 financial results presentation on March 27, 2025, highlighting significant improvements in profitability...
Investing.com -- Moody's Ratings announced on March 10, 2025, an upgrade to the long-term corporate family rating (CFR) for Viridien S.A., taking it from B3 to B2. Viridien's probability of default...
Viridien SA reported its financial results for the fourth quarter of 2024, revealing stable revenue performance and a notable improvement in net cash flow. The company's stock price reacted...
ATLANTA, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the Company), a development-stage biopharmaceutical company focused on advancing first-in class, non-opioid, Nav...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review